Published in Circulation on July 05, 2005
SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation (2004) 3.01
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol (1998) 1.85
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78
Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67
[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46
The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39
[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39
Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res (1999) 1.34
The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30
Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 1.14
The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13
The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11
Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00
Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit. J Pharm Pharmacol (1986) 0.98
Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98
Amounts of feverfew in commercial preparations of the herb. Lancet (1986) 0.97
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94
First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94
Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J (2010) 0.91
The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth Heart J (2011) 0.91
Rationale and design of the CAREFUL study : The yield of CARdiogenetic scrEening in First degree relatives of sudden cardiac and UnexpLained death victims <45 years. Neth Heart J (2010) 0.90
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90
Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A (2005) 0.88
High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet (2005) 0.87
Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS). Neth Heart J (2014) 0.87
Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol (1987) 0.85
Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet (2005) 0.85
Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J (2007) 0.84
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. Neth Heart J (2009) 0.84
Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome. Neth Heart J (2008) 0.83
GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J (2006) 0.81
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
Netherlands Heart Journal: accepted into PubMed Central! Neth Heart J (2006) 0.81
Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Neth Heart J (2011) 0.80
Gene polymorphisms and cardiac arrhythmias. Europace (2003) 0.80
Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome. Neth Heart J (2010) 0.80
Recurrent and founder mutations in inherited cardiac diseases in the Netherlands. Neth Heart J (2009) 0.80
[Hypertrophic cardiomyopathy: a genetically-carried heart disease]. Ned Tijdschr Geneeskd (2002) 0.79
An extract of feverfew inhibits interactions of human platelets with collagen substrates. Thromb Res (1987) 0.79
Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease. Neth Heart J (2007) 0.79
Characterization of the rat connexin40 promoter: two Sp1/Sp3 binding sites contribute to transcriptional activation. Cardiovasc Res (2000) 0.78
cDNA and deduced amino acid sequence of a novel cytochrome P-450 from female rat liver mRNA with high homology to P-450 IIC family. Nucleic Acids Res (1990) 0.78
Towards a better risk stratification for sudden cardiac death in patients with structural heart disease. Neth Heart J (2009) 0.77
Flush after syncope: not always an arrhythmia. J Cardiovasc Electrophysiol (2006) 0.77
A large family characterised by nocturnal sudden death. Neth Heart J (2002) 0.77
Effects of an extract of feverfew on endothelial cell integrity and on cAMP in rabbit perfused aorta. J Pharm Pharmacol (1988) 0.77
T-wave alternans in a patient with long-QT syndrome type 3. Neth Heart J (2006) 0.77
Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters. Neth Heart J (2007) 0.77
Feverfew--an antithrombotic drug? Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 0.77
De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome. Clin Genet (2013) 0.76
Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study. Neth Heart J (2011) 0.76
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 2. Neth Heart J (2004) 0.75
Nightly phenomena, day time work? Neth Heart J (2004) 0.75
Brugada syndrome. Eur Heart J (2002) 0.75
Familial primary arrhythmia syndromes: Nice to know or need to know. Neth Heart J (2002) 0.75
Primary prevention: prime time?: ICD trials (and tribulations). Neth Heart J (2004) 0.75
TDI-echocardiography: a new screening tool for long QT syndrome? Eur J Echocardiogr (2003) 0.75
Palpitations and dizziness in a 65-year-old man. Neth Heart J (2006) 0.75
Primary ventricular fibrillation in acute myocardial infarction: an inherited disease? Neth Heart J (2001) 0.75
It's not what you think it is. Neth Heart J (2005) 0.75
Case histories: increasing role for major journals. Neth Heart J (2009) 0.75
Diversity in cardiac sodium channel disease phenotype in transgenic mice carrying a single SCN5A mutation. Neth Heart J (2007) 0.75
A fainting lady with some extrasystoles. Neth Heart J (2004) 0.75
COMPANION - a friend indeed. Neth Heart J (2003) 0.75
One more time: bibliometric analysis of scientific output remains complicated. Neth Heart J (2011) 0.75
Should I be worried? Neth Heart J (2006) 0.75
Rationale of the SEAS study: Serial Echocardiography After Subarachnoid haemorrhage, a prospective national, multicentre, multidisciplinary, cohort study to evaluate cardiac abnormalities following intracranial haemorrhage. Neth Heart J (2006) 0.75
An extended family suddenly confronted with a life-threatening hereditary arrhythmia. Neth Heart J (2005) 0.75
ECG screening of newborns to avoid sudden infant death syndrome? Neth Heart J (2006) 0.75
Recent breakthroughs in the genetics of atrial fibrillation. Neth Heart J (2003) 0.75
The ECG of a (cardio)myopathy? Neth Heart J (2005) 0.75
'Brugada ECG' elicited by imipramine overdose. Neth Heart J (2004) 0.75
Not just any ICD device in patients with long-QT syndrome. Neth Heart J (2007) 0.75
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1. Neth Heart J (2004) 0.75
Right you are. Neth Heart J (2005) 0.75
Cardiogenetic counselling in a non-university hospital. Neth Heart J (2007) 0.75
Genotype-phenotype analysis of Jervell and Lange-Nielsen syndrome in six families from Saudi Arabia. Clin Genet (2013) 0.75
[Congenital long QT-syndrome: the cause of recurrent syncope and sudden death at a young age]. Ned Tijdschr Geneeskd (2007) 0.75
Reversed remodelling of dilated left sided cardiomyopathy after upgrading from VVIR to VVIR biventricular pacing. Europace (2002) 0.75
Inhibition of the behaviour of human polynuclear leukocytes by an extract of Chrysanthemum parthenium. Planta Med (1988) 0.75
Should you be worried? Neth Heart J (2014) 0.75
Should you be worried? Neth Heart J (2014) 0.75
[The optimal treatment of chronic heart failure with beta-blockers may be dependent upon the genetic background of the patient]. Ned Tijdschr Geneeskd (2007) 0.75
A patient with recurrent syncope and ST-elevation on the electrocardiogram. Europace (2004) 0.75
Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets. Biomed Biochim Acta (1988) 0.75